Latest News - Apollon Formularies enters binding agreement which could lead to sale of all assets

Apollon Formularies
  • Home
  • About
    • About Us
    • Expertise
  • Our Products
    • Products
    • Regulations
  • Our Team
  • News
  • Investor Relations
    • Advisers
    • AQSE Rule 4.14
    • Corporate Governance
    • Presentations & Reports
    • Regulatory News
    • Shareholder Information
    • Share Price Information
  • Contact
Schedule Appointment

Latest News and Media

  1. Home
  2. Latest News and Media

Latest Media Coverage

Jan 21, 2023

Apollon Formularies enters binding agreement which could lead to sale of all assets
View Article >

Sept 30, 2022

Apollon Formularies looking to develop export opportunities
View Article >

Sept 05, 2022

Apollon Formularies chief executive to be keynote speaker at US cannabis conference
View Article >

July 26, 2022

Apollon Formularies makes key Jamaica acquisition that helps it fulfil its strategy
View Article >

Latest Social

Tweets by apollon_uk

Latest Videos

Archive

  • Apollon Formularies plc Acquires Intellectual Property From Aion Therapeutic

    May 05, 2022
    View Article >

  • Apollon Formularies strikes out for the first time internationally as it teams up with South African cannabis company

    Mar 02, 2022
    View Article >

  • Apollon Formularies set for US listing on OTCQB

    Feb 09, 2022
    View Article >

  • Apollon Formularies names Dr Herbert Fritsche as director

    Jan 27, 2022
    View Article >

  • Apollon Formularies CEO says is an 'exciting time’ to be in the medical cannabis business

    Jan 25, 2022
    View Article >

  • Apollon Formularies names Dr Archibald McDonald as clinical trials director

    Jan 15, 2022
    View Article >

  • Apollon Formularies appoints long-time advisor and shareholder as non-exec director

    Jan 12, 2022
    View Article >

  • Apollon Formularies inks agreements with 'over a dozen' cannabis growers in Jamaica

    Jan 10, 2022
    View Article >

  • Apollon Formularies gets green light for Jamaica medical cannabis licence renewal

    Jan 06, 2022
    View Article >

  • Apollon Formularies begins treating cancer patients in 'huge milestone' in Kingston, Jamaica

    Dec 15, 2021
    View Article >

  • Apollon Formularies says new Jamaica facility produces 20-litres of high-quality cannabis oil a day

    Dec 15, 2021
    View Article >

  • Apollon Formularies begins treating cancer patients at Jamaica's Kingston centre

    Dec 09, 2021
    View Article >

  • Apollon Formularies expands Jamaica production facility

    Sept 15, 2021
    View Article >

  • Apollon Formularies cannabis formulations show early promise in prostate cancer

    July 19, 2021
    View Article >

  • Apollon Formularies appoints medical director to head new Jamaican facility

    July 15, 2021
    View Article >

  • Apollon Formularies says independent lab tests show its cannabis formulations successfully killed triple-negative breast cancer

    June 28, 2021
    View Article >

  • Increased global demand for Jamaican cannabis - CLA.

    June 28, 2021
    View Article >

  • Endexx says international subsidiary granted ‘Herb House’ license to sell cannabis in Jamaica.

    June 23, 2021
    View Article >

  • New data from UK Medical Cannabis Registry presented at symposium

    June 22, 2021
    View Article >

  • Apollon Formularies leases Jamaican cancer treatment facility

    June 14, 2021
    View Article >

  • Scotland's first patients prescribed legal cannabis

    June 10, 2021
    View Article >

  • Jamaica government seeking to overhaul marijuana regulations

    June 4, 2021
    View Article >

Apollon Formularies

Ruthven Road
Jamaica

Phone: +44 20 7907 9314
Email: info@apollon.org.uk

Quick Links

  • Home
  • About
  • Services
  • Products
  • Regulations
  • Our Team
  • Contact
  • News & Media

Investor Relations

  • Advisers
  • AQSE Rule 4.14
  • Presentations & Reports
  • Regulatory News
  • Shareholder Information
  • Share Price Information
© Copyright Apollon Formularies PLC. All Rights Reserved
Developed by Digma.io